p53 signaling is involved in leptin-induced growth of hepatic and breast cancer cells

다국어 초록 (Multilingual Abstract)

Leptin, an adipokine predominantly produced from adipose tissue, is well known to induce tumor growth. However, underlying molecular mechanisms are not established yet. While p53 has long been well recognized as a potent tumor suppressor gene, accumulating evidence has also indicated its potential role in growth and survival of cancer cells depending on experimental environments. In the present study, we examined if p53 signaling is implicated in leptin-induced growth of cancer cells. Herein, we demonstrated that leptin treatment significantly increased p53 protein expression in both hepatic (HepG2) and breast (MCF-7) cancer cells without significant effect on mRNA expression. Enhanced p53 expressionby leptin was mediated via modulation of ubiquitination, in particular ubiquitin specific protease 2 (USP2)-dependent manner. Furthermore, gene silencing of p53 by small interfering RNA (siRNA) suppressed leptin-induced growth of hepatic and breast cancer cells, indicating the role of p53 signaling in tumor growth by leptin. In addition, we also showed that knockdown of p53 restored suppression of caspase-3 activity by leptin through modulating Bax expression and prevented leptin-induced cell cycle progression, implying the involvement of p53 signaling in the regulation of both apoptosis and cell cycle progression in cancer cells treated with leptin. Taken together, the results in the present study demonstrated the potential role of p53 signaling in leptin-induced tumor growth.

참고문헌 (Reference)

1 Elledge RM, "p53mutation and tamoxifen resistance in breast cancer" 1 : 1203-1208, 1995

2 Scherz-Shouval R, "p53-dependent regulation of autophagy protein LC3 supports cancer cell survival under prolonged starvation" 107 : 18511-18516, 2010

3 Levine AJ, "p53, the cellular gatekeeper for growth and division" 88 : 323-331, 1997

4 Kastan MB, "Wild-type p53 : tumors can't stand it" 128 : 837-840, 2007

5 Lukashchuk N, "Ubiquitination and degradation of mutant p53" 27 : 8284-8595, 2007

6 Nepal S, "Ubiquitin specific protease 2 acts as a key modulator for the regulation of cell cycle by adiponectin and leptin in cancer cells" 412 : 44-55, 2015

7 Liu J, "Tumor suppressor p53 and its gain-offunction mutants in cancer" 46 : 170-179, 2014

8 Lo PK, "The prosurvival activity of p53 protects cells from UV-induced apoptosis by inhibiting c-Jun NH2-terminal kinase activity and mitochondrial death signaling" 64 : 8736-8745, 2004

9 Lee JT, "The multiple levels of regulation by p53 ubiquitination" 17 : 86-92, 2010

10 Andò S, "The multifactorial role of leptin in driving the breast cancer microenvironment" 8 : 263-275, 2011

11 Graner E, "The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer" 5 : 253-261, 2004

12 Eskelinen EL, "The dual role of autophagy in cancer" 11 : 294-300, 2011

13 Jänicke RU, "The dark side of a tumor suppressor : anti-apoptotic p53" 15 : 959-976, 2008

14 Sablina AA, "The antioxidant function of the p53 tumor suppressor" 11 : 1306-1313, 2005

15 Samuel T, "The G2/M regulator 14-3-3sigma prevents apoptosis through sequestration of Bax" 276 : 45201-45206, 2001

16 Nagasawa H, "Relationship between radiation-induced G1 phase arrest and p53 function in human tumor cells" 55 : 1842-1846, 1995

17 Saroj Nepal, "Regulatory Role of Autophagy in Globular Adiponectin-Induced Apoptosis in Cancer Cells" 한국응용약물학회 22 (22): 384-389, 2014

18 Kastan MB, "Participation of p53 protein in the cellular response to DNA damage" 51 : 6304-6311, 1991

19 Surmacz E., "Obesity hormone leptin : a new target in breast Shrestha M and Park PH cancer?" 9 : 301-, 2007

20 van Kruijsdijk RC, "Obesity and cancer : the role of dysfunctional adipose tissue" 18 : 2569-2578, 2009

21 Kelesidis T, "Narrative review : the role of leptin in human physiology : emerging clinical applications" 152 : 93-100, 2010

22 Lim LY, "Mutant p53 mediates survival of breast cancer cells" 101 : 1606-1612, 2009

23 Oren M, "Mutant p53 gain-of-function in cancer" 2 : a001107-, 2010

24 Lin YC, "Mechanisms underlying the pro-survival pathway of p53 in suppressing mitotic death induced by adriamycin" 20 : 258-267, 2008

25 Myers MG, "Mechanisms of leptin action and leptin resistance" 70 : 537-556, 2008

26 Vousden KH, "Live or let die : the cell's response to p53" 2 : 594-604, 2002

27 Perera CN, "Leptin-regulated gene expression in MCF-7 breast cancer cells : mechanistic insights into leptin-regulated mammary tumor growth and progression" 199 : 221-233, 2008

28 Ptak A, "Leptin stimulation of cell cycle and inhibition of apoptosis gene and protein expression in OVCAR-3 ovarian cancer cells" 43 : 394-403, 2013

29 Chen C, "Leptin induces proliferation and anti-apoptosis in human hepatocarcinoma cells by up-regulating cyclin D1 and down-regulating Bax via a Janus kinase 2-linked pathway" 14 : 513-529, 2007

30 Garofalo C, "Leptin and cancer" 207 : 12-22, 2006

31 Brito AF, "Hepatocellular carcinoma and chemotherapy : the role of p53" 58 : 381-386, 2012

32 Kim MJ, "Globular adiponectin inhibits ethanolinduced reactive oxygen species production through modulation of NADPH oxidase in macrophages : involvement of liver kinase B1/AMP-activated protein kinase pathway" 86 : 284-296, 2014

33 Nepal S, "Globular adiponectin inhibits ethanol-induced apoptosis in HepG2 cells through heme oxygenase-1 induction" 84 : 974-983, 2012

34 Dittmer D, "Gain of function mutations in p53" 4 : 42-46, 1993

35 Guweidhi A, "Enhanced expression of 14-3-3sigma in pancreatic cancer and its role in cell cycle regulation and apoptosis" 25 : 1575-1585, 2004

36 Sacco JJ, "Emerging roles of deubiquitinases in cancer-associated pathways" 62 : 140-157, 2010

37 Chipuk JE, "Dissecting p53-dependent apoptosis" 13 : 994-1002, 2006

38 Li CY, "Diminished capacity for p53 in mediating a radiation-induced G1 arrest in established human tumor cell lines" 11 : 1885-1892, 1995

39 DeLeo AB, "Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse" 76 : 2420-2424, 1979

40 Oren M, "Decision making by p53 : life, death and cancer" 10 : 431-442, 2003

41 Yee KS, "Complicating the complexity of p53" 26 : 1317-1322, 2005

42 da Silva SD, "Clinicopathological significance of ubiquitin-specific protease 2a(USP2a), fatty acid synthase(FASN), and ErbB2 expression in oral squamous cell carcinomas" 45 : 134-139, 2009

43 O'Connor PM, "Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents" 57 : 4285-4300, 1997

44 Park HJ, "Cell cycle progression and apoptosis after irradiation in an acidic environment" 7 : 729-738, 2000

45 Nepal S, "Autophagy induction by leptin contributes to suppression of apoptosis in cancer cells and xenograft model : involvement of p53/FoxO3A axis" 6 : 7166-7181, 2015

46 Jain K, "Autophagy in breast cancer and its implications for therapy" 3 : 251-265, 2013

47 Bhutia SK, "Autophagy : cancer's friend or foe" 118 : 61-95, 2013

48 Lassus P, "Anti-apoptotic activity of low levels of wild-type p53" 15 : 4566-4573, 1996

49 Nepal S, "Activation of autophagy by globular adiponectin attenuates ethanol-induced apoptosis in HepG2 cells : involvement of AMPK/FoxO3A axis" 1833 : 2111-2125, 2013

50 Little JB, "Absence of radiationinduced G1 arrest in two closely related human lymphoblast cell lines that differ in p53 status" 270 : 11033-11036, 1995

51 Nagasawa H, "Absence of a radiation-induced first-cycle G1-S arrest in p53+ human tumor cells synchronized by mitotic selection" 58 : 2036-2041, 1998